| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_27e1ea5f65e8f958e48f1a9d53fdbb45 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00 |
| filingDate |
2021-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be2791ea250d722257db84caaa3cc1fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6048a15e0d7e0d11265b54c44ac7e6c0 |
| publicationDate |
2022-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2022099204-A1 |
| titleOfInvention |
Methods of using platelet factor 4 as an antimicrobial agent |
| abstract |
The present disclosure relates to methods of inhibiting and/or reducing the severity of a bacterial infection comprising the administration of Platelet Factor 4 (PF4). The bacterial infection can be caused by Gram-negative or Gram-positive bacteria. The bacterial infection can also have progressed to sepsis or peritonitis. In particular implementations, a method of inhibiting and/or reducing the severity of a Staphylococcus aureus infection is described, including a MRSA infection. |
| priorityDate |
2020-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |